MENU
+Compare
AKTX
Stock ticker: NASDAQ
AS OF
Apr 2, 03:21 PM (EDT)
Price
$1.14
Change
+$0.04 (+3.64%)
Capitalization
29.12M

AKTX Akari Therapeutics plc Forecast, Technical & Fundamental Analysis

Akari Therapeutics PLC is a clinical stage biopharmaceutical company... Show more

AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AKTX with price predictions
Apr 01, 2025

AKTX's Stochastic Oscillator slumps into oversold zone

The Stochastic Oscillator for AKTX moved into oversold territory on April 01, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for AKTX crossed bullishly above the 50-day moving average on March 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AKTX advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 96 cases where AKTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AKTX moved out of overbought territory on March 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on April 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AKTX as a result. In of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AKTX turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

AKTX moved below its 50-day moving average on April 01, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AKTX broke above its upper Bollinger Band on March 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AKTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.391).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AKTX is expected to report earnings to rise 1,566.67% to -100 cents per share on September 27

Akari Therapeutics plc AKTX Stock Earnings Reports
Q2'23
Est.
$-1.00
Q1'23
Est.
$-0.06
Q4'22
Missed
by $0.08
Q3'22
Beat
by $0.02
Q4'21
Est.
$0.00
The last earnings report on June 01 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 6.41K shares outstanding, the current market capitalization sits at 29.12M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
22 Boston Wharf Road
Phone
+1 929 274-7510
Employees
12
Web
https://www.akaritx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XGN3.930.34
+9.47%
Exagen
VMI288.473.10
+1.09%
Valmont Industries
GIS59.72-0.07
-0.12%
General Mills
DGII27.72-0.11
-0.40%
Digi International
PAMT12.01-0.13
-1.07%
Pamt Corp

AKTX and Stocks

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
-11.29%
KPRX - AKTX
30%
Poorly correlated
-2.66%
DSGN - AKTX
24%
Poorly correlated
-6.61%
SPRY - AKTX
24%
Poorly correlated
-0.40%
MOLN - AKTX
23%
Poorly correlated
-1.03%
GLTO - AKTX
23%
Poorly correlated
-9.03%
More